Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)

Abstract Background Epistaxis is the most common symptom of hereditary hemorrhagic telangiectasia (HHT), affecting more than 98% of adults with HHT, with significant impact on quality of life. Floseal® has been shown to be effective for the management of anterior epistaxis, but has yet to be thoroug...

Full description

Saved in:
Bibliographic Details
Main Authors: John M. Lee, Vincent Wu, Marie E. Faughnan, Andrea Lasso, Andrea Figol, Shaun J. Kilty
Format: Article
Language:English
Published: SAGE Publishing 2019-10-01
Series:Journal of Otolaryngology - Head and Neck Surgery
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40463-019-0379-y
Tags: Add Tag
No Tags, Be the first to tag this record!